- Whole-genome sequencing reveals host factors underlying critical COVID-19 [https://doi.org/10.1038/s41586-022-04576-6]
- Genetic mechanisms of severe Covid-19 [https://doi.org/10.1038/s41586-020-03065-y]
- Two key takeaways from a year of pandemic research [https://doi.org/10.1097/CCM.0000000000005078]
- Neandertal DNA associated with severe illness with COVID-19 [https://doi.org/10.1073/pnas.2026309118]
- Identification of a novel protective genetic variant against severe COVID-19 [https://doi.org/10.1016/j.retram.2022.103333]
- Rare genetic variants influencing COVID-19 outcomes [https://doi.org/10.1371/journal.pgen.1010367]
- Biomarkers of COVID-19 and technologies to combat SARS-CoV-2 [https://doi.org/10.1016/j.abst.2020.08.001]
- The ACE2 coronavirus receptor [https://doi.org/10.1161/CIRCULATIONAHA.121.057888]
- Endomembrane targeting of human OAS1 p46 augments antiviral activity. [https://doi.org/10.7554/eLife.71047]
- Clonal hematopoiesis is not significantly associated with COVID-19 disease severity. [https://doi.org/10.1182/blood.2022015721]
- A prenylated dsRNA sensor protects against severe COVID-19. [https://doi.org/10.1126/science.abj3624]
- Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity. [https://doi.org/10.1007/s00439-021-02397-7]
- Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19. [https://doi.org/10.1038/s41588-021-00996-8]
- Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19. [https://doi.org/10.1101/2021.04.01.21254789]
- A catalog of associations between rare coding variants and COVID-19 outcomes. [https://doi.org/10.1101/2020.10.28.20221804]
- Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals. [https://doi.org/10.1016/j.ajhg.2021.05.017]
